28 February, 2024 | Online
18:00-19:00 CET
Interstitial lung diseases (ILDs) are complex and heterogeneous diseases. The use of traditional diagnostic classification in ILD can lead to suboptimal management, which is worsened by not considering the molecular pathways, biological complexity, and disease phenotypes. The multidisciplinary approach to ILDs, beyond the pharmacological management, may improve patient's outcomes. A multidisciplinary care team model is a potential way to implement a "treatable traits" strategy into clinical practice with the aim of improving patients' outcomes.
The webinar will include 45 minutes of lectures, and 15 minutes of interactive discussions with participants.